A modern approach to an old disease: glycosaminoglycans (GAGs) therapy in osteoarthritis
AboutMedicine Highlights Anno I, N. 4, ottobre 2013
EULAR 2013, Madrid
Indice
- Introductory remarks: Pascal Richette (France)
- Novel discoveries on the mechanism of action of GAGs in OA: Yves Henrotin (Belgium)
- From clinical studies to real life: recent data on the clinical efficacy of CS in OA and its potential to reduce the consumption of NSAIDs: Pascal Richette (France)
- Ultrasound applications in rheumatology: Giorgio Tamborrini (Switzerland)
- Tailoring the viscoinduction/viscosupplementation treatment to the joint affected by OA and its effects on the disease stage: Alberto Migliore (Italy)
- Discussion and concluding remarks: Pascal Richette (France)